ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	24/185	167/7206	4.02662484095e-12
ko04380	Osteoclast differentiation	20/185	134/7206	1.40217837599e-10
ko04668	TNF signaling pathway	18/185	120/7206	1.13693919925e-09
ko05161	Hepatitis B	21/185	173/7206	2.38466634548e-09
ko04621	NOD-like receptor signaling pathway	20/185	157/7206	2.50611918785e-09
ko04620	Toll-like receptor signaling pathway	16/185	100/7206	3.80419848511e-09
ko05162	Measles	17/185	120/7206	8.26960993393e-09
ko05168	Herpes simplex infection	20/185	182/7206	3.29631626224e-08
ko04630	Jak-STAT signaling pathway	17/185	132/7206	3.57507966566e-08
ko05160	Hepatitis C	18/185	153/7206	5.81562937942e-08
ko05167	Kaposi's sarcoma-associated herpesvirus infection	19/185	191/7206	3.6331728843e-07
ko05145	Toxoplasmosis	15/185	126/7206	6.68887037124e-07
ko04064	NF-kappa B signaling pathway	13/185	96/7206	8.65033610847e-07
ko05142	Chagas disease (American trypanosomiasis)	15/185	130/7206	1.00450077229e-06
ko04622	RIG-I-like receptor signaling pathway	10/185	62/7206	3.29271973128e-06
ko04060	Cytokine-cytokine receptor interaction	17/185	191/7206	7.14720588641e-06
ko04933	AGE-RAGE signaling pathway in diabetic complications	14/185	135/7206	8.31745047337e-06
ko04917	Prolactin signaling pathway	11/185	87/7206	1.21484989978e-05
ko05133	Pertussis	11/185	87/7206	1.21484989978e-05
ko04210	Apoptosis	16/185	180/7206	1.36747080885e-05
ko05140	Leishmaniasis	10/185	75/7206	1.90099694408e-05
ko04658	Th1 and Th2 cell differentiation	11/185	96/7206	3.12940032935e-05
ko04931	Insulin resistance	13/185	137/7206	4.5657535174e-05
ko04657	IL-17 signaling pathway	10/185	87/7206	7.02788456296e-05
ko04623	Cytosolic DNA-sensing pathway	7/185	41/7206	7.04541846087e-05
ko05321	Inflammatory bowel disease (IBD)	8/185	56/7206	8.02599647933e-05
ko04920	Adipocytokine signaling pathway	10/185	89/7206	8.54467382617e-05
ko04217	Necroptosis	14/185	178/7206	0.000180747452902
ko05152	Tuberculosis	14/185	187/7206	0.000302368453887
ko04672	Intestinal immune network for IgA production	6/185	37/7206	0.000316332774195
ko04659	Th17 cell differentiation	10/185	106/7206	0.000367185781562
ko05166	HTLV-I infection	18/185	292/7206	0.000477967014601
ko04115	p53 signaling pathway	8/185	74/7206	0.000574543067576
ko04932	Non-alcoholic fatty liver disease (NAFLD)	13/185	182/7206	0.000776412889972
ko05132	Salmonella infection	9/185	98/7206	0.000877605243521
ko05340	Primary immunodeficiency	5/185	30/7206	0.000893351684008
ko05212	Pancreatic cancer	8/185	83/7206	0.00123586815692
ko04660	T cell receptor signaling pathway	10/185	124/7206	0.00126336594697
ko01522	Endocrine resistance	10/185	124/7206	0.00126336594697
ko04662	B cell receptor signaling pathway	8/185	88/7206	0.00180644882033
ko04218	Cellular senescence	12/185	177/7206	0.00192883573714
ko04080	Neuroactive ligand-receptor interaction	2/185	423/7206	0.00214082509225
ko05134	Legionellosis	7/185	74/7206	0.00276727739261
ko04068	FoxO signaling pathway	11/185	167/7206	0.00369282135753
ko00140	Steroid hormone biosynthesis	5/185	41/7206	0.00374081506988
ko00643	Styrene degradation	2/185	4/7206	0.00380182684624
ko04211	Longevity regulating pathway	9/185	123/7206	0.00424398510446
ko04976	Bile secretion	7/185	80/7206	0.00429547621775
ko04062	Chemokine signaling pathway	12/185	201/7206	0.00545147159541
ko05144	Malaria	5/185	45/7206	0.00561599164537
ko01521	EGFR tyrosine kinase inhibitor resistance	8/185	106/7206	0.00573708548085
ko05210	Colorectal cancer	7/185	86/7206	0.00639058436236
ko05169	Epstein-Barr virus infection	12/185	206/7206	0.0066069618905
ko05215	Prostate cancer	8/185	111/7206	0.00753925842507
ko04624	Toll and Imd signaling pathway	5/185	49/7206	0.00807314665238
ko05120	Epithelial cell signaling in Helicobacter pylori infection	7/185	92/7206	0.00916730253709
ko00362	Benzoate degradation	2/185	6/7206	0.00918699993221
ko05150	Staphylococcus aureus infection	4/185	36/7206	0.0130450690017
ko04066	HIF-1 signaling pathway	8/185	123/7206	0.0135785726472
ko00120	Primary bile acid biosynthesis	3/185	20/7206	0.0137584039568
ko04610	Complement and coagulation cascades	6/185	79/7206	0.0155914864892
ko05131	Shigellosis	6/185	82/7206	0.0184493602721
ko04137	Mitophagy - animal	6/185	82/7206	0.0184493602721
ko04915	Estrogen signaling pathway	8/185	131/7206	0.019206700587
ko04960	Aldosterone-regulated sodium reabsorption	4/185	41/7206	0.0203189338695
ko05220	Chronic myeloid leukemia	6/185	85/7206	0.0216471423555
ko04012	ErbB signaling pathway	7/185	109/7206	0.021731354743
ko05221	Acute myeloid leukemia	5/185	63/7206	0.0223519821044
ko00401	Novobiocin biosynthesis	1/185	1/7206	0.0256730502359
ko05323	Rheumatoid arthritis	6/185	89/7206	0.0264667525604
ko03320	PPAR signaling pathway	5/185	69/7206	0.0316405271521
ko04010	MAPK signaling pathway	14/185	321/7206	0.0457302401707
ko05143	African trypanosomiasis	3/185	32/7206	0.0478913244473
ko04930	Type II diabetes mellitus	4/185	54/7206	0.0491959444328